{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:32:02Z","timestamp":1794976322592,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7945","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,1,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    DNA mismatch repair-deficient (MMR-d) cancers present an abundance of neoantigens that is thought to explain their exceptional responsiveness to immune checkpoint blockade (ICB)\n                    <jats:sup>1,2<\/jats:sup>\n                    . Here, in contrast to other cancer types\n                    <jats:sup>3\u20135<\/jats:sup>\n                    , we observed that 20 out of 21 (95%) MMR-d cancers with genomic inactivation of \u03b22-microglobulin (encoded by\n                    <jats:italic>B2M<\/jats:italic>\n                    ) retained responsiveness to\u00a0ICB, suggesting the involvement of immune effector cells other than CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells in this context. We next identified a strong association between\n                    <jats:italic>B2M<\/jats:italic>\n                    inactivation and increased infiltration by \u03b3\u03b4 T cells in MMR-d cancers. These \u03b3\u03b4 T cells mainly comprised the V\u03b41 and V\u03b43 subsets, and expressed high levels of PD-1, other activation markers, including cytotoxic molecules, and a broad repertoire of killer-cell immunoglobulin-like receptors. In vitro, PD-1\n                    <jats:sup>+<\/jats:sup>\n                    \u03b3\u03b4 T cells that were isolated from MMR-d colon cancers exhibited enhanced reactivity\u00a0to human leukocyte antigen (HLA)-class-I-negative MMR-d colon cancer cell lines and\n                    <jats:italic>B2M<\/jats:italic>\n                    -knockout patient-derived tumour organoids compared with antigen-presentation-proficient cells. By comparing paired tumour samples from patients with MMR-d colon cancer that were obtained before and after dual PD-1 and CTLA-4 blockade, we found that immune checkpoint blockade substantially increased the frequency of \u03b3\u03b4 T cells in B2M-deficient cancers. Taken together, these data indicate that \u03b3\u03b4 T cells contribute to the response to immune checkpoint blockade in patients with HLA-class-I-negative MMR-d colon cancers, and underline the potential of \u03b3\u03b4 T cells in cancer immunotherapy.\n                  <\/jats:p>","DOI":"10.1038\/s41586-022-05593-1","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T12:02:56Z","timestamp":1673438576000},"page":"743-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":321,"title":["\u03b3\u03b4 T cells are effectors of immunotherapy in cancers with HLA class I defects"],"prefix":"10.1038","volume":"613","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-7036","authenticated-orcid":false,"given":"Natasja L.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"van de Haar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-5075","authenticated-orcid":false,"given":"Vivien","family":"Veninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-6174","authenticated-orcid":false,"given":"Myriam","family":"Chalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke E.","family":"Ijsselsteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7150-3068","authenticated-orcid":false,"given":"Manon","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-9478","authenticated-orcid":false,"given":"Jitske","family":"van den Bulk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-7704","authenticated-orcid":false,"given":"John B.","family":"Haanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurien J.","family":"Zeverijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit S.","family":"Geurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs F.","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-8636","authenticated-orcid":false,"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk M. W.","family":"Verheul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0517-8804","authenticated-orcid":false,"given":"Ton N.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1656-6995","authenticated-orcid":false,"given":"Lodewyk F. A.","family":"Wessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6122-1024","authenticated-orcid":false,"given":"Noel F. C. C.","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-9586","authenticated-orcid":false,"given":"Emile E.","family":"Voest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"5593_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/363558a0","volume":"363","author":"Y Ionov","year":"1993","unstructured":"Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558\u2013561 (1993).","journal-title":"Nature"},{"key":"5593_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature24673","volume":"552","author":"G Germano","year":"2017","unstructured":"Germano, G. et al. Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth. Nature 552, 116\u2013120 (2017).","journal-title":"Nature"},{"key":"5593_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky, J. M. et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375, 819\u2013829 (2016).","journal-title":"N. Engl. J. Med."},{"key":"5593_CR4","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1158\/2159-8290.CD-17-0593","volume":"7","author":"S Gettinger","year":"2017","unstructured":"Gettinger, S. et al. Impaired HLA class i antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer. Cancer Discov. 7, 1420\u20131435 (2017).","journal-title":"Cancer Discov."},{"key":"5593_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01062-w","volume":"8","author":"M Sade-Feldman","year":"2017","unstructured":"Sade-Feldman, M. et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nat. Commun. 8, 1136 (2017).","journal-title":"Nat. Commun."},{"key":"5593_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409\u2013413 (2017).","journal-title":"Science"},{"key":"5593_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman, M. J. et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet. Oncol. 18, 1182\u20131191 (2017).","journal-title":"Lancet. Oncol."},{"key":"5593_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman, M. J. et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J. Clin. Oncol. 36, 773\u2013779 (2018).","journal-title":"J. Clin. Oncol."},{"key":"5593_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi, M. et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat. Med. 26, 566\u2013576 (2020).","journal-title":"Nat. Med."},{"key":"5593_CR10","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0002-9440(10)65436-3","volume":"154","author":"R Dolcetti","year":"1999","unstructured":"Dolcetti, R. et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am. J. Pathol. 154, 1805\u20131813 (1999).","journal-title":"Am. J. Pathol."},{"key":"5593_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568\u2013571 (2014).","journal-title":"Nature"},{"key":"5593_CR12","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","volume":"20","author":"JM Taube","year":"2014","unstructured":"Taube, J. M. et al. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin. Cancer Res. 20, 5064\u20135074 (2014).","journal-title":"Clin. Cancer Res."},{"key":"5593_CR13","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0960-9822(02)70795-1","volume":"6","author":"DC Bicknell","year":"1996","unstructured":"Bicknell, D. C., Kaklamanis, L., Hampson, R., Bodmer, W. F. & Karran, P. Selection for \u03b22-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr. Biol. 6, 1695\u20131697 (1996).","journal-title":"Curr. Biol."},{"key":"5593_CR14","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1158\/0008-5472.CAN-05-0044","volume":"65","author":"M Kloor","year":"2005","unstructured":"Kloor, M. et al. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res. 65, 6418\u20136424 (2005).","journal-title":"Cancer Res."},{"key":"5593_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-33","volume":"7","author":"JW Dierssen","year":"2007","unstructured":"Dierssen, J. W. et al. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. BMC Cancer 7, 33 (2007).","journal-title":"BMC Cancer"},{"key":"5593_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41416-019-0421-x","volume":"120","author":"ME Ijsselsteijn","year":"2019","unstructured":"Ijsselsteijn, M. E. et al. Revisiting immune escape in colorectal cancer in the era of immunotherapy. Br. J. Cancer 120, 815\u2013818 (2019).","journal-title":"Br. J. Cancer"},{"key":"5593_CR17","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1073\/pnas.94.5.1896","volume":"94","author":"EA Hughes","year":"1997","unstructured":"Hughes, E. A., Hammond, C. & Cresswell, P. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl Acad. Sci. USA 94, 1896\u20131901 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5593_CR18","doi-asserted-by":"crossref","unstructured":"Middha, S. et al. Majority of B2M-mutant and -deficient colorectal carcinomas achieve clinical benefit from immune checkpoint inhibitor therapy and are microsatellite instability-high. JCO Precis. Oncol. 3, 1\u201314 (2019).","DOI":"10.1200\/PO.18.00321"},{"key":"5593_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1084\/jem.169.4.1277","volume":"169","author":"V Groh","year":"1989","unstructured":"Groh, V. et al. Human lymphocytes bearing T cell receptor \u03b3\/\u03b4 are phenotypically diverse and evenly distributed throughout the lymphoid system. J. Exp. Med. 169, 1277\u20131294 (1989).","journal-title":"J. Exp. Med."},{"key":"5593_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","volume":"19","author":"B Silva-Santos","year":"2019","unstructured":"Silva-Santos, B., Mensurado, S. & Coffelt, S. B. \u03b3\u03b4 T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat. Rev. Cancer 19, 392\u2013404 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"5593_CR21","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/eji.1830271111","volume":"27","author":"F Halary","year":"1997","unstructured":"Halary, F. et al. Control of self-reactive cytotoxic T lymphocytes expressing \u03b3\u03b4 T cell receptors by natural killer inhibitory receptors. Eur. J. Immunol. 27, 2812\u20132821 (1997).","journal-title":"Eur. J. Immunol."},{"key":"5593_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2019-318672","volume":"69","author":"NL de Vries","year":"2020","unstructured":"de Vries, N. L. et al. High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity. Gut 69, 691\u2013703 (2020).","journal-title":"Gut"},{"key":"5593_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-019-1600-x","volume":"574","author":"DL van der Velden","year":"2019","unstructured":"van der Velden, D. L. et al. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs. Nature 574, 127\u2013131 (2019).","journal-title":"Nature"},{"key":"5593_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","volume":"5","author":"P Danaher","year":"2017","unstructured":"Danaher, P. et al. Gene expression markers of tumor infiltrating leukocytes. J. Immunother. Cancer 5, 18 (2017).","journal-title":"J. Immunother. Cancer"},{"key":"5593_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210\u2013216 (2019).","journal-title":"Nature"},{"key":"5593_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05072-0","volume":"9","author":"T Duhen","year":"2018","unstructured":"Duhen, T. et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat. Commun. 9, 2724 (2018).","journal-title":"Nat. Commun."},{"key":"5593_CR27","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1158\/2159-8290.CD-21-0219","volume":"11","author":"M Kwon","year":"2021","unstructured":"Kwon, M. et al. Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability-high gastric cancer. Cancer Discov. 11, 2168\u20132185 (2021).","journal-title":"Cancer Discov."},{"key":"5593_CR28","doi-asserted-by":"publisher","first-page":"eaax9364","DOI":"10.1126\/scitranslmed.aax9364","volume":"11","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. An innate-like V\u03b41+ \u03b3\u03b4 T cell compartment in the human breast is associated with remission in triple-negative breast cancer. Sci. Transl. Med. 11, eaax9364 (2019).","journal-title":"Sci. Transl. Med."},{"key":"5593_CR29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s43018-022-00376-z","volume":"3","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. A local human V\u03b41 T cell population is associated with survival in nonsmall-cell lung cancer. Nat. Cancer 3, 696\u2013709 (2022).","journal-title":"Nat. Cancer"},{"key":"5593_CR30","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1084\/jem.183.4.1681","volume":"183","author":"MJ Maeurer","year":"1996","unstructured":"Maeurer, M. J. et al. Human intestinal V\u03b41+ lymphocytes recognize tumor cells of epithelial origin. J. Exp. Med. 183, 1681\u20131696 (1996).","journal-title":"J. Exp. Med."},{"key":"5593_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00262-012-1353-y","volume":"62","author":"GM Siegers","year":"2013","unstructured":"Siegers, G. M., Ribot, E. J., Keating, A. & Foster, P. J. Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with feraheme for cellular MRI. Cancer Immunol. Immunother. 62, 571\u2013583 (2013).","journal-title":"Cancer Immunol. Immunother."},{"key":"5593_CR32","doi-asserted-by":"publisher","first-page":"e992749","DOI":"10.4161\/2162402X.2014.992749","volume":"4","author":"D Wu","year":"2015","unstructured":"Wu, D. et al. Ex vivo expanded human circulating V\u03b41 \u03b3\u03b4T cells exhibit favorable therapeutic potential for colon cancer. Oncoimmunology 4, e992749 (2015).","journal-title":"Oncoimmunology"},{"key":"5593_CR33","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","volume":"22","author":"AR Almeida","year":"2016","unstructured":"Almeida, A. R. et al. Delta one T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion\/differentiation and preclinical proof of concept. Clin. Cancer Res. 22, 5795\u20135804 (2016).","journal-title":"Clin. Cancer Res."},{"key":"5593_CR34","doi-asserted-by":"publisher","first-page":"e125884","DOI":"10.1172\/jci.insight.125884","volume":"4","author":"J Mikulak","year":"2019","unstructured":"Mikulak, J. et al. NKp46-expressing human gut-resident intraepithelial V\u03b41 T cell subpopulation exhibits high antitumor activity against colorectal cancer. JCI Insight 4, e125884 (2019).","journal-title":"JCI Insight"},{"key":"5593_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun, A. M., Thommen, D. S. & Schumacher, T. N. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer 20, 218\u2013232 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"5593_CR36","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","volume":"279","author":"V Groh","year":"1998","unstructured":"Groh, V., Steinle, A., Bauer, S. & Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial \u03b3\u03b4 T cells. Science 279, 1737\u20131740 (1998).","journal-title":"Science"},{"key":"5593_CR37","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1073\/pnas.96.12.6879","volume":"96","author":"V Groh","year":"1999","unstructured":"Groh, V. et al. Broad tumor-associated expression and recognition by tumor-derived \u03b3\u03b4 T cells of MICA and MICB. Proc. Natl Acad. Sci. USA 96, 6879\u20136884 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5593_CR38","doi-asserted-by":"publisher","first-page":"9172","DOI":"10.1158\/0008-5472.CAN-04-2417","volume":"64","author":"A Poggi","year":"2004","unstructured":"Poggi, A. et al. V\u03b41 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. Cancer Res. 64, 9172\u20139179 (2004).","journal-title":"Cancer Res."},{"key":"5593_CR39","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause, R. J., Pritchard, C. C., Shendure, J. & Salipante, S. J. Classification and characterization of microsatellite instability across 18 cancer types. Nat. Med. 22, 1342\u20131350 (2016).","journal-title":"Nat. Med."},{"key":"5593_CR40","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41591-020-1006-1","volume":"26","author":"FZ Cader","year":"2020","unstructured":"Cader, F. Z. et al. A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma. Nat. Med. 26, 1468\u20131479 (2020).","journal-title":"Nat. Med."},{"key":"5593_CR41","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1158\/2159-8290.CD-20-0987","volume":"11","author":"G Germano","year":"2021","unstructured":"Germano, G. et al. CD4 T cell-dependent rejection of beta-2 microglobulin null mismatch repair-deficient tumors. Cancer Discov. 11, 1844\u20131859 (2021).","journal-title":"Cancer Discov."},{"key":"5593_CR42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"5593_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676\u2013689 (2018).","journal-title":"Cancer Cell"},{"key":"5593_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.immuni.2019.08.004","volume":"51","author":"V Thorsson","year":"2019","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 51, 411\u2013412 (2019).","journal-title":"Immunity"},{"key":"5593_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep13321","volume":"5","author":"MN Huang","year":"2015","unstructured":"Huang, M. N. et al. MSIseq: software for assessing microsatellite instability from catalogs of somatic mutations. Sci. Rep. 5, 13321 (2015).","journal-title":"Sci. Rep."},{"key":"5593_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"5593_CR47","doi-asserted-by":"crossref","unstructured":"Shale, C. et al. Unscrambling cancer genomes via integrated analysis of structural variation and copy number. Cell Genomics 2, 100112 (2022).","DOI":"10.1016\/j.xgen.2022.100112"},{"key":"5593_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"5593_CR49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261\u2013272 (2020).","journal-title":"Nat. Methods"},{"key":"5593_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"5593_CR51","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"5593_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"5593_CR53","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/00313025.2010.493871","volume":"42","author":"G Hall","year":"2010","unstructured":"Hall, G. et al. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Pathology 42, 409\u2013413 (2010).","journal-title":"Pathology"},{"key":"5593_CR54","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"5593_CR55","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"5593_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41592-019-0433-8","volume":"16","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S. et al. MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices. Nat. Methods 16, 619\u2013626 (2019).","journal-title":"Nat. Methods"},{"key":"5593_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","volume":"36","author":"L Haghverdi","year":"2018","unstructured":"Haghverdi, L., Lun, A. T. L., Morgan, M. D. & Marioni, J. C. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat. Biotechnol. 36, 421\u2013427 (2018).","journal-title":"Nat. Biotechnol."},{"key":"5593_CR58","doi-asserted-by":"crossref","unstructured":"McInnes, L., Healy, J. & Melville, J. UMAP: uniform manifold approximation and projection for dimension reduction. Preprint at arXiv https:\/\/arxiv.org\/abs\/1802.03426 (2018).","DOI":"10.21105\/joss.00861"},{"key":"5593_CR59","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.3389\/fimmu.2019.02534","volume":"10","author":"ME Ijsselsteijn","year":"2019","unstructured":"Ijsselsteijn, M. E., van der Breggen, R., Farina Sarasqueta, A., Koning, F. & de Miranda, N. F. C. C. A 40-marker panel for high dimensional characterization of cancer immune microenvironments by imaging mass cytometry. Front. Immunol. 10, 2534\u20132534 (2019).","journal-title":"Front. Immunol."},{"key":"5593_CR60","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","volume":"16","author":"S Berg","year":"2019","unstructured":"Berg, S. et al. ilastik: interactive machine learning for (bio)image analysis. Nat. Methods 16, 1226\u20131232 (2019).","journal-title":"Nat. Methods"},{"key":"5593_CR61","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/cyto.a.24480","volume":"99","author":"ME Ijsselsteijn","year":"2021","unstructured":"Ijsselsteijn, M. E., Somarakis, A., Lelieveldt, B. P. F., H\u00f6llt, T. & de Miranda, N. Semi-automated background removal limits data loss and normalises imaging mass cytometry data. Cytometry A 99, 1187\u20131197 (2021).","journal-title":"Cytometry A"},{"key":"5593_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).","journal-title":"Genome Biol."},{"key":"5593_CR63","doi-asserted-by":"crossref","unstructured":"Somarakis, A., Van Unen, V., Koning, F., Lelieveldt, B. P. F. & Hollt, T. ImaCytE: visual exploration of cellular microenvironments for imaging mass cytometry data. IEEE Trans. Vis. Comp. Graph. 27, 98\u2013110 (2019).","DOI":"10.1109\/TVCG.2019.2931299"},{"key":"5593_CR64","first-page":"2579","volume":"9","author":"LJP van der Maaten","year":"2008","unstructured":"van der Maaten, L. J. P. & Hinton, G. E. Visualizing high-dimensional data using t-SNE. J. Mach. Learn. Res. 9, 2579\u20132605 (2008).","journal-title":"J. Mach. Learn. Res."},{"key":"5593_CR65","doi-asserted-by":"crossref","unstructured":"H\u00f6llt, T. et al. Cytosplore: interactive immune cell phenotyping for large single-cell datasets. Comput. Graph. Forum 35, 171\u2013180 (2016).","DOI":"10.1111\/cgf.12893"},{"key":"5593_CR66","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra, K. K. et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell 174, 1586\u20131598 (2018).","journal-title":"Cell"},{"key":"5593_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","volume":"15","author":"CM Cattaneo","year":"2020","unstructured":"Cattaneo, C. M. et al. Tumor organoid-T-cell coculture systems. Nat. Protoc. 15, 15\u201339 (2020).","journal-title":"Nat. Protoc."},{"key":"5593_CR68","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3389\/fimmu.2017.00776","volume":"8","author":"I Dutta","year":"2017","unstructured":"Dutta, I., Postovit, L. M. & Siegers, G. M. Apoptosis induced via gamma delta T cell antigen receptor \u201cblocking\u201d antibodies: a cautionary tale. Front. Immunol. 8, 776 (2017).","journal-title":"Front. Immunol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05593-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05593-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05593-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T23:46:01Z","timestamp":1676072761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05593-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":68,"journal-issue":{"issue":"7945","published-print":{"date-parts":[[2023,1,26]]}},"alternative-id":["5593"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-05593-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742490995.793597487","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.742490995.793597750","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.742490995.793597657","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"assertion":[{"value":"16 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.C. has performed an advisory role or offered expert testimony for BMS, MSD and NUMAB; has received honoraria from BMS and Roche; and has received financing of scientific research from Roche, BMS and MSD. J.B.H. has received research funding from BMS; and has performed an advisory role for BMS.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}